KIR B or not to be?...that is the question for ALL

Blood

Volumn 124, Issue 17, 2014, Pages 2623-2624

  Verneris, Michael R ^a   Miller, Jeffrey S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A11 ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR B; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER SURVIVAL; CELL ADHESION; CELL KILLING; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DONOR SELECTION; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; LEUKEMIA RELAPSE; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NOTE; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; T CELL DEPLETION; BLOOD DONOR; FEMALE; GENETICS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROCEDURES;

BLOOD DONORS; FEMALE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, KIR;

EID: 84908231551     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-09-596395     Document Type: Note

References (10)

1. Oevermann L, Michaelis SU, Mezger M, et al. KIR B haplotype donors confer a reduced risk of relapse after haploidentical transplantation in children with ALL. Blood. 2014;124(17):2744-2747.
2. Ljunggren HG, Kärre K. In search of the 'missing self ': MHC molecules and NK cell recognition. Immunol Today. 1990;11(7):237-244.
3. Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol. 2006;18(3):145-150.
4. Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7(6):753-763.
5. Cooley S, Weisdorf DJ, Guethlein LA, et al. Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. J Immunol. 2014;192(10):4592-4600.
6. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436(7051):709-713.
7. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaëlsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood. 2010;115(6):1166-1174.
8. Cooley S, Weisdorf DJ, Guethlein LA, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411-2419.
9. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100.
10. Elias S, Yamin R, Golomb L, et al. Immune evasion by oncogenic proteins of acute myeloid leukemia. Blood. 2014;123(10):1535-1543.